More than half of all US adults are eligible for semaglutide therapy, according to a research letter published online.

Lower noninvasive test cut-points are recommended among Hispanic adults with MASLD in order to optimize surveillance of fibrosis.

Low-FODMAP and gluten-free combined diets improve physical and psychological symptoms of irritable bowel syndrome.

For patients with heart failure with preserved ejection fraction, tirzepatide yields a reduced risk for a composite of death from cardiovascular causes or worsening heart failure.

Combination treatment with entinostat and nivolumab results in durable responses in a small subset of patients with advanced pancreatic ductal adenocarcinoma (PDA).

The risk for VTE was reduced among Military Health Systems beneficiaries who were vaccinated vs unvaccinated against COVID-19.

Suicide risk is not only elevated among individuals with psychiatric disorders, but also among individuals with medical conditions.

Semaglutide and liraglutide are associated with a reduced risk for hospitalization due to alcohol use disorder (AUD).

Mortality risk, especially due to dermatological and endocrine causes, was higher among patients with type 1 diabetes compared with type 2 diabetes.

Digital health tools have the potential to improve health outcomes among individuals with IBS, but more research is needed.

COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025).